Edmond DE Rothschild Holding S.A. Buys New Shares in CME Group Inc. $CME

Edmond DE Rothschild Holding S.A. purchased a new stake in CME Group Inc. (NASDAQ:CMEFree Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 33,467 shares of the financial services provider’s stock, valued at approximately $7,391,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. BlackRock Inc. acquired a new position in shares of CME Group during the second quarter valued at about $6,749,965,000. Norges Bank acquired a new stake in CME Group during the fourth quarter worth about $1,523,241,000. Bank of New York Mellon Corp bought a new position in CME Group during the second quarter valued at about $867,313,000. Alphabet Inc. bought a new position in CME Group during the second quarter valued at about $769,376,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in CME Group in the 2nd quarter valued at approximately $629,771,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group Stock Down 1.7%

NASDAQ CME opened at $266.94 on Thursday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The stock’s 50 day moving average is $250.89 and its two-hundred day moving average is $279.81. The company has a market capitalization of $95.99 billion, a price-to-earnings ratio of 22.64, a PEG ratio of 3.16 and a beta of 0.23. CME Group Inc. has a 1-year low of $218.31 and a 1-year high of $329.16.

CME Group (NASDAQ:CMEGet Free Report) last released its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The company had revenue of $1.71 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same period in the prior year, the company posted $2.96 EPS. The company’s revenue was up .8% compared to the same quarter last year. Equities analysts forecast that CME Group Inc. will post 12.27 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be given a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date is Wednesday, September 9th. CME Group’s dividend payout ratio is 44.11%.

Insiders Place Their Bets

In related news, Director William R. Shepard acquired 325 shares of the company’s stock in a transaction on Thursday, June 25th. The stock was purchased at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the purchase, the director directly owned 260,442 shares of the company’s stock, valued at $60,050,111.94. The trade was a 0.12% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.30% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on CME. Erste Group Bank downgraded CME Group from a “buy” rating to a “hold” rating in a research report on Friday, June 5th. Raymond James Financial restated an “outperform” rating and set a $320.00 price objective on shares of CME Group in a research report on Thursday, July 2nd. Wall Street Zen lowered CME Group from a “sell” rating to a “strong sell” rating in a research note on Saturday, August 1st. The Goldman Sachs Group reduced their target price on CME Group from $267.00 to $245.00 and set a “sell” rating for the company in a research report on Tuesday, June 30th. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of CME Group from a “buy” rating to a “hold” rating and decreased their price target for the stock from $286.00 to $270.00 in a research note on Wednesday. Nine equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, CME Group presently has an average rating of “Hold” and an average target price of $288.56.

View Our Latest Stock Report on CME Group

About CME Group

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

See Also

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.